Free Trial
OTCMKTS:BIOGY

BioGaia AB (publ) (BIOGY) Stock Price, News & Analysis

BioGaia AB (publ) logo
$12.45 0.00 (0.00%)
As of 11/4/2026

About BioGaia AB (publ) Stock (OTCMKTS:BIOGY)

Advanced

Key Stats

Today's Range
$12.45
▼
$12.45
50-Day Range
$12.45
▼
$12.45
52-Week Range
$9.64
▼
$12.45
Volume
N/A
Average Volume
267 shs
Market Capitalization
N/A
P/E Ratio
2.96
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioGaia AB (publ) is a Swedish health-care company that develops, markets and sells probiotic products. The company focuses on scientifically documented probiotic strains, particularly Lactobacillus reuteri, which are used in products intended to support digestive and oral health.

BioGaia’s product portfolio includes probiotic drops, tablets, lozenges and other formulations for infants, children and adults. Its products are marketed for areas including infant digestive health, gastrointestinal well-being and oral care, and are sold under the BioGaia brand as well as through selected partner brands.

Founded in 1990 and headquartered in Stockholm, Sweden, BioGaia distributes its products through pharmacies, health-care providers, retailers and online channels. The company serves customers internationally through distributors and commercial partners, with products available in numerous markets across Europe, Asia, the Americas and other regions.

AI Generated. May Contain Errors.

Receive BIOGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioGaia AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BIOGY Stock News Headlines

BioGaia AB (publ) (BIOGY) Q3 2026 Earnings Call Transcript
What Elon Musk's Cybercab Reveal Could Mean for Investors
Jeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He points to a new AI project tied to Musk's Cybercab reveal. Brown says Musk has opened major investment windows before, with PayPal, Tesla, and SpaceX marking milestones in tech history. He believes a fourth may open by October 30.tc pixel
SB1 Markets upgrades Biogaia to Buy, more attractive setup now
Worldquant no longer a public short seller in Biogaia
See More Headlines

BIOGY Stock Analysis - Frequently Asked Questions

BioGaia AB (publ)'s stock was trading at $11.00 on January 1st, 2026. Since then, BIOGY shares have increased by 13.2% and is now trading at $12.45.

BioGaia AB (publ)'s stock split on the morning of Thursday, May 26th 2022.The 2.5-1 split was announced on Thursday, May 26th 2022. The newly issued shares were issued to shareholders after the closing bell on Thursday, May 26th 2022. An investor that had 100 shares of stock prior to the split would have 250 shares after the split.

Shares of BIOGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:BIOGY
CIK
1572957
Fax
N/A
Employees
200
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
2.96
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:BIOGY) was last updated on 11/4/2026 by MarketBeat.com Staff.
From Our Partners